March 10, 2009 – Heartbeat Experts, the leading global provider of Key Opinion Leader (KOL) identification and consulting services, reported a 275% growth in revenues for 2008 over the previous year. The practice, which focuses on identifying Key Opinion Leaders for top pharmaceutical, biotech and medical device companies, saw a surge in growth in both the U.S. and Europe and signed 15 new clients in 2008.
“Our medical experts have uncovered a serious unmet need across our Life Sciences clients,” said Jonah Meyers, President of Heartbeat Experts. “With the ongoing trend of Life Sciences companies reducing their sales forces and relying more on their expert community of doctors (KOLs) to spread the word about new and existing brands, our identification services have become ever so vital.”
According to Larry Cohen, EVP at Heartbeat Experts, “We’ve employed our KOL identification and KOL influence mapping services in areas as diverse as emerging market KOLs, guideline committee KOLs, and difficult to find rising stars and are continually surveying thousands of physicians to pinpoint the leaders.”
“A KOL today is not always a KOL tomorrow,” said Matt Phillips, Vice President at Heartbeat experts. “It’s imperative that our clients change and update their KOL lists and strategic KOL plans to mirror the current changes in scientific data and threats from competitors.” Heartbeat Experts, with offices in five countries and expertise in twelve major therapeutic areas, is the leading provider of Key Opinion Leader Identification and consulting services. Heartbeat Experts works with fifteen of the top thirty pharmaceutical and biotech companies on KOL identification, KOL Segmentation, KOL Profiling, KOL Influence Mapping, and KOL Planning.
For more information or to schedule a consultation call the U.S. Headquarters at (212) 941-9041 or the European Headquarters at (32) 2 400 00 22 or visit www.heartbeatexperts.com.
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved